Wang F, Li L, Sun X, Cai X, Wang J, Luo H
Cell Death Discov. 2025; 11(1):97.
PMID: 40074730
PMC: 11903659.
DOI: 10.1038/s41420-025-02385-0.
Okamoto K, Nozawa H, Ozawa T, Yamamoto Y, Yokoyama Y, Emoto S
Cell Death Discov. 2025; 11(1):67.
PMID: 39971948
PMC: 11840149.
DOI: 10.1038/s41420-025-02348-5.
Tran N, Chang T, Chi N, Lai K, Chen H, Fong Y
Int J Biol Sci. 2025; 21(3):1144-1157.
PMID: 39897041
PMC: 11781170.
DOI: 10.7150/ijbs.106827.
Qiu W, Akanyibah F, Xia Y, Ocansey D, Mao F, Liang Y
Int J Mol Med. 2024; 55(2).
PMID: 39704210
PMC: 11670865.
DOI: 10.3892/ijmm.2024.5474.
Chen Y, Liu S, Tan S, Zheng Y, Chen Y, Yang C
Gut Microbes. 2024; 16(1):2423043.
PMID: 39523457
PMC: 11556274.
DOI: 10.1080/19490976.2024.2423043.
A novel m7G-related miRNA prognostic signature for predicting clinical outcome and immune microenvironment in colon cancer.
Zhu Z, Xie Y, Yin M, Peng L, Zhu H
J Cancer. 2024; 15(18):6086-6102.
PMID: 39440054
PMC: 11493006.
DOI: 10.7150/jca.99173.
Nanoplatelets modified with RVG for targeted delivery of miR-375 and temozolomide to enhance gliomas therapy.
Yang T, Zhang N, Liu Y, Yang R, Wei Z, Liu F
J Nanobiotechnology. 2024; 22(1):623.
PMID: 39402578
PMC: 11476726.
DOI: 10.1186/s12951-024-02895-6.
MiRNA expression affects survival in patients with obstructive sleep apnea and metastatic colorectal cancer.
Soccio P, Moriondo G, Scioscia G, Tondo P, Bruno G, Giordano G
Noncoding RNA Res. 2024; 10:91-97.
PMID: 39315340
PMC: 11419774.
DOI: 10.1016/j.ncrna.2024.09.008.
Contribution of PKS+ to colon carcinogenesis through the inhibition of exosomal miR-885-5p.
He X, Ren E, Dong L, Yuan P, Zhu J, Liu D
Heliyon. 2024; 10(18):e37346.
PMID: 39315148
PMC: 11417213.
DOI: 10.1016/j.heliyon.2024.e37346.
A New Frontier in Phytotherapy: Harnessing the Therapeutic Power of Medicinal Herb-derived miRNAs.
Feng Y
Curr Pharm Des. 2024; 30(38):3009-3017.
PMID: 39162273
DOI: 10.2174/0113816128310724240730072626.
KLF7 enhances the invasion and migration of colorectal cancer cells via the miR-139-5p/TPD52 axis.
Zhang J, Li Z, Han J, Tian Z, Meng Q, Niu W
Cancer Biol Ther. 2024; 25(1):2385172.
PMID: 39097779
PMC: 11299624.
DOI: 10.1080/15384047.2024.2385172.
Unraveling the MicroRNA tapestry: exploring the molecular dynamics of locoregional recurrent rectal cancer.
Meyer N, Kotnik N, Noubissi Nzeteu G, van Kempen L, Mastik M, Bockhorn M
Front Oncol. 2024; 14:1407217.
PMID: 39070144
PMC: 11272531.
DOI: 10.3389/fonc.2024.1407217.
Predictors of early colorectal cancer metastasis to lymph nodes: providing rationale for therapy decisions.
Song X, Li J, Zhu J, Kong Y, Zhou Y, Wang Z
Front Oncol. 2024; 14:1371599.
PMID: 39035744
PMC: 11257837.
DOI: 10.3389/fonc.2024.1371599.
Mapping alternative splicing events in colorectal cancer.
Zheng Y, Zhong G, Song Q, Zhang H, Wang S, Lin C
Discov Oncol. 2024; 15(1):280.
PMID: 39004679
PMC: 11247070.
DOI: 10.1007/s12672-024-01149-z.
MiR-135b-5p promotes cetuximab resistance in colorectal cancer by regulating FOXN3.
Peng C, Li X, Yao Y, Nie Y, Fan L, Zhu C
Cancer Biol Ther. 2024; 25(1):2373497.
PMID: 38967961
PMC: 11229718.
DOI: 10.1080/15384047.2024.2373497.
C1GALT1 induces the carcinogenesis of thyroid cancer through regulation by miR-141-3p and GLUT1.
Huang L, Li Z, Xu Z, Yu R, Ding C, Sun T
Heliyon. 2024; 10(11):e31778.
PMID: 38845937
PMC: 11153184.
DOI: 10.1016/j.heliyon.2024.e31778.
PSAT1 mediated EMT of colorectal cancer cells by regulating Pl3K/AKT signaling pathway.
Wang M, Zhang H, Lu Z, Su W, Tan Y, Wang J
J Cancer. 2024; 15(10):3183-3198.
PMID: 38706897
PMC: 11064270.
DOI: 10.7150/jca.93789.
Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance.
Ellakwa D, Mushtaq N, Khan S, Jabbar A, Abdelmalek M, Wadan A
Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(8):5617-5630.
PMID: 38619588
DOI: 10.1007/s00210-024-03076-w.
MiR-15b-3p weakens bicalutamide sensitivity in prostate cancer via targeting KLF2 to suppress ferroptosis.
Zhang C, Yu H, Bai X, Zhou X, Feng Z, Li Y
J Cancer. 2024; 15(8):2306-2317.
PMID: 38495481
PMC: 10937263.
DOI: 10.7150/jca.92379.
miR-135b Aggravates Fusobacterium nucleatum-Induced Cisplatin Resistance in Colorectal Cancer by Targeting KLF13.
Zeng W, Pan J, Ye G
J Microbiol. 2024; 62(2):63-73.
PMID: 38402337
DOI: 10.1007/s12275-023-00100-1.